A detailed history of Public Sector Pension Investment Board transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Public Sector Pension Investment Board holds 54,122 shares of GILD stock, worth $4.88 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares
54,122
Previous 47,722 13.41%
Holding current value
$4.88 Million
Previous $3.27 Million 38.55%
% of portfolio
0.02%
Previous 0.02%

Shares

28 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$66.59 - $83.99 $426,176 - $537,536
6,400 Added 13.41%
54,122 $4.54 Million
Q2 2024

Aug 14, 2024

BUY
$63.15 - $72.88 $1.27 Million - $1.47 Million
20,120 Added 72.89%
47,722 $3.27 Million
Q1 2024

May 14, 2024

SELL
$71.58 - $87.29 $57,264 - $69,832
-800 Reduced 2.82%
27,602 $2.02 Million
Q4 2023

Feb 14, 2024

SELL
$73.27 - $83.09 $7.7 Million - $8.73 Million
-105,068 Reduced 78.72%
28,402 $2.3 Million
Q3 2023

Nov 22, 2023

BUY
$73.94 - $80.67 $1.04 Million - $1.13 Million
14,029 Added 11.75%
133,470 $10 Million
Q2 2023

Aug 14, 2023

SELL
$76.01 - $86.7 $1.35 Million - $1.54 Million
-17,755 Reduced 12.94%
119,441 $9.21 Million
Q1 2023

May 12, 2023

SELL
$77.31 - $88.08 $1.47 Million - $1.67 Million
-18,956 Reduced 12.14%
137,196 $11.4 Million
Q4 2022

Feb 14, 2023

SELL
$62.32 - $89.47 $29.8 Million - $42.8 Million
-477,868 Reduced 75.37%
156,152 $13.4 Million
Q3 2022

Nov 14, 2022

BUY
$59.54 - $68.01 $30.6 Million - $34.9 Million
513,370 Added 425.5%
634,020 $39.1 Million
Q2 2022

Aug 12, 2022

SELL
$57.72 - $65.01 $3.19 Million - $3.6 Million
-55,352 Reduced 31.45%
120,650 $7.46 Million
Q1 2022

May 13, 2022

SELL
$57.92 - $72.58 $29 Million - $36.3 Million
-500,310 Reduced 73.98%
176,002 $10.5 Million
Q4 2021

Feb 14, 2022

SELL
$64.88 - $73.64 $17.3 Million - $19.7 Million
-267,160 Reduced 28.32%
676,312 $49.1 Million
Q3 2021

Nov 12, 2021

BUY
$67.69 - $73.03 $30.2 Million - $32.6 Million
446,870 Added 89.99%
943,472 $65.9 Million
Q2 2021

Aug 13, 2021

BUY
$63.47 - $69.35 $18.9 Million - $20.7 Million
297,850 Added 149.86%
496,602 $34.2 Million
Q1 2021

May 14, 2021

BUY
$60.0 - $68.46 $850,920 - $970,899
14,182 Added 7.68%
198,752 $12.8 Million
Q4 2020

Feb 12, 2021

SELL
$56.65 - $64.55 $2.68 Million - $3.05 Million
-47,302 Reduced 20.4%
184,570 $10.8 Million
Q3 2020

Nov 13, 2020

BUY
$62.1 - $78.08 $6.89 Million - $8.66 Million
110,900 Added 91.67%
231,872 $14.7 Million
Q2 2020

Aug 14, 2020

SELL
$72.34 - $84.0 $397,870 - $462,000
-5,500 Reduced 4.35%
120,972 $9.31 Million
Q1 2020

May 14, 2020

SELL
$62.63 - $80.22 $23.5 Million - $30 Million
-374,590 Reduced 74.76%
126,472 $9.46 Million
Q4 2019

Feb 14, 2020

SELL
$61.62 - $67.78 $152,571 - $167,823
-2,476 Reduced 0.49%
501,062 $32.6 Million
Q3 2019

Nov 14, 2019

BUY
$62.51 - $69.0 $13 Million - $14.4 Million
208,283 Added 70.54%
503,538 $31.9 Million
Q2 2019

Aug 14, 2019

BUY
$61.87 - $69.38 $3.68 Million - $4.13 Million
59,500 Added 25.24%
295,255 $19.9 Million
Q1 2019

May 14, 2019

BUY
$62.53 - $70.05 $1.38 Million - $1.54 Million
21,996 Added 10.29%
235,755 $15.3 Million
Q4 2018

Feb 14, 2019

BUY
$60.54 - $79.0 $357,186 - $466,100
5,900 Added 2.84%
213,759 $13.4 Million
Q3 2018

Nov 14, 2018

SELL
$71.28 - $78.92 $7.99 Million - $8.85 Million
-112,100 Reduced 35.04%
207,859 $16 Million
Q2 2018

Aug 14, 2018

BUY
$64.88 - $75.68 $16 Million - $18.7 Million
247,000 Added 338.55%
319,959 $22.7 Million
Q1 2018

May 10, 2018

BUY
$72.84 - $88.8 $203,952 - $248,640
2,800 Added 3.99%
72,959 $5.5 Million
Q3 2017

Nov 14, 2017

BUY
$72.11 - $85.47 $5.06 Million - $6 Million
70,159
70,159 $0

Others Institutions Holding GILD

About GILEAD SCIENCES, INC.


  • Ticker GILD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,253,369,984
  • Market Cap $113B
  • Description
  • Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...
More about GILD
Track This Portfolio

Track Public Sector Pension Investment Board Portfolio

Follow Public Sector Pension Investment Board and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Public Sector Pension Investment Board, based on Form 13F filings with the SEC.

News

Stay updated on Public Sector Pension Investment Board with notifications on news.